You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 69 No. 6, December 1954 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

STUDIES ON REDUCTION OF INTESTINAL FLORA

Preoperative Treatment of Patients with Lesions of Colon or Rectum

C. V. MUNTHE FOG, M.D.

AMA Arch Surg. 1954;69(6):858-869.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

MARSHALL, Bratton, White, and Litchfield,1 in 1940, published a report of investigations made with sulfaguanidine, a sulfonamide showing relatively little tendency to being absorbed. Its use had enabled them to reduce the number of colibacilli in the fecal flora of mice, and they recommended it for the treatment of infectious intestinal diseases in humans.

After this, sulfaguanidine was used preoperatively to reduce the coliflora prior to surgical intervention involving the colon or rectum. There was some dissatisfaction with this remedy, however, as some of it was absorbed and its effect on the coliflora was rather uncertain.*

The synthesization and testing of succinylsulfathiazole and phthalylsulfathiazole by Moore and Miller4 and Poth and Ross,5 respectively, was therefore a considerable advance in this field. Treatment with these drugs reduced the coliflora in the feces to less than 1,000 bacteria per gram in 93% of the patients in five to seven . . . [Full Text PDF of this Article]


Author Affiliations

COPENHAGEN

From the University Institute of General Pathology (Head, Prof. VK. A. Jensen) and the Department of Surgery I. Kommunehospitalet (Head, Prof. O. Mikkelsen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1954 American Medical Association. All Rights Reserved.